• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee

Research review

Chromium benefits: what the research does and doesn't show

Chromium's one consistent positive finding is in people who already have diabetes; trials in people without diabetes, and on weight or cravings, found effects too small or too preliminary to act on.

By Electric Tiger Editorial

The evidence doesn't support chromium as a general-purpose supplement for blood sugar, weight or appetite in people who don't have diabetes. The one clear positive signal in the research — improved glycemic control — shows up only in people who already have diabetes, and the trials on weight and cravings found effects too small, or too preliminary, to act on.

What the evidence doesn't support

It doesn't support chromium lowering blood sugar in people without diabetes: a 2002 meta-analysis of 15 randomized trials found no association between chromium supplementation and glucose or insulin levels in non-diabetic subjects. It doesn't support meaningful weight loss — a meta-analysis of 11 randomized trials found an average difference of half a kilogram against placebo, with the authors calling the clinical relevance uncertain. And it doesn't support the mechanism some marketing implies: the FDA's own 2006 evidence-based review concluded that the relationship between chromium picolinate and insulin resistance is "highly uncertain." For the fuller picture on chromium and blood sugar specifically — including where the diabetes evidence is stronger — see blood sugar supplements: what the evidence supports.

What the trials found

A 2014 systematic review and meta-analysis pooled 25 randomized controlled trials of chromium supplementation in people with diabetes and found a mean reduction in HbA1c of 0.55 percentage points and in fasting plasma glucose of 1.15 mmol/L, with glycemic control improving most reliably at doses above 200 mcg/day of chromium. Adverse events didn't differ between chromium and placebo groups. That's a real, if modest, effect — and it was measured exclusively in people already diagnosed with diabetes, not in a general population. A separate 2002 meta-analysis of 15 RCTs (618 participants total) found the opposite pattern in people without diabetes: no effect on glucose or insulin, and the diabetic-population data itself was called inconclusive outside one large Chinese trial that drove most of the pooled result.

On weight: a 2013 systematic review and meta-analysis of 11 randomized trials in overweight and obese adults found chromium supplementation produced a statistically significant but small average weight loss of 0.5 kg (about 1 pound) compared with placebo, with high heterogeneity between trials and adverse events including watery stools, vertigo, headaches and urticaria. The authors were explicit that the clinical relevance of half a kilogram is uncertain, and called for longer trials with more consistent methods.

On appetite and cravings: a single small 8-week trial randomized 42 overweight women who reported carbohydrate cravings to chromium picolinate (roughly 1,000 mcg/day) or placebo. The chromium group reported less hunger and fewer fat cravings and ate less food at measured meals, but body weight only trended downward without reaching statistical significance (p = 0.08). It's one trial, in a self-selected population already reporting cravings, and hasn't been replicated at that dose in a broader population.

Questions people ask

Is chromium good for you?

As a nutrient, yes — it's essential, meaning the body needs a small amount and can't make it. As a supplement taken beyond ordinary dietary amounts for a specific outcome, the evidence above is thin outside people who already have diabetes.

What does chromium do for the body?

It's involved in normal carbohydrate and fat metabolism, though the mechanism isn't well understood — the FDA's own review calls it "highly uncertain." See what is chromium for the basic nutrition facts.

Does chromium help with sugar cravings?

One small trial in 42 overweight women who already reported cravings found less hunger and fewer fat cravings on chromium picolinate versus placebo over 8 weeks. That's a single trial in a specific, self-selected group — not a general finding that chromium reduces cravings for everyone.

Does chromium help you lose weight?

A meta-analysis of 11 trials found an average difference of half a kilogram versus placebo — a real but small number that the reviewers themselves called of uncertain clinical relevance. It isn't a weight-loss treatment.

Is chromium good for diabetics?

Most of the data in this category comes from people with diagnosed diabetes, where trials found a modest improvement in HbA1c and fasting glucose. That's a finding about a specific diagnosed population, not a self-care recommendation — blood sugar supplements: what the evidence supports covers this in full, and anyone managing diabetes should do so with a doctor, not a supplement search.

What is chromium picolinate used for?

It's the most commonly sold and most-studied supplement form of chromium, used in the diabetes, weight and craving trials described above. See what is chromium for how it differs from other forms.

When to talk to a doctor

Diabetes, prediabetes and clinically significant weight concerns are medical conditions best managed with a doctor, not a supplement search. Chromium is not a treatment for diabetes or obesity, and nothing in the trials above supports using it as a substitute for medical care, medication or a structured weight program a doctor might recommend. If you take medication for diabetes, talk to your doctor before adding chromium — the same glucose-lowering effect the trials measured is a reason to be cautious, not a reason to self-treat. See who should not take chromium and chromium and medications: what to check.

Sources

  1. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes Journal of clinical pharmacy and therapeutics · 2014 · PMID 24635480
  2. Glucose and insulin responses to dietary chromium supplements: a meta-analysis The American journal of clinical nutrition · 2002 · PMID 12081828
  3. Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration Nutrition reviews · 2006 · PMID 16958312The FDA's own review of the evidence called the link between chromium picolinate and insulin resistance highly uncertain, even while allowing a narrow qualified claim.
  4. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials Obesity reviews : an official journal of the International Association for the Study of Obesity · 2013 · PMID 23495911A meta-analysis of 11 trials found chromium produced a small but statistically significant average weight loss of half a kilogram versus placebo, with the reviewers calling its clinical relevance uncertain.
  5. Effects of chromium picolinate on food intake and satiety Diabetes technology & therapeutics · 2008 · PMID 18715218A small 8-week trial in 42 overweight women who already reported cravings found less hunger and fewer fat cravings on chromium picolinate versus placebo, but no significant change in body weight.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.